GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (STU:LMQ) » Definitions » EV-to-FCF

Oxford BioDynamics (STU:LMQ) EV-to-FCF : -1.15 (As of Apr. 01, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Oxford BioDynamics EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Oxford BioDynamics's Enterprise Value is €14.60 Mil. Oxford BioDynamics's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €-12.75 Mil. Therefore, Oxford BioDynamics's EV-to-FCF for today is -1.15.

The historical rank and industry rank for Oxford BioDynamics's EV-to-FCF or its related term are showing as below:

STU:LMQ' s EV-to-FCF Range Over the Past 10 Years
Min: -114.45   Med: -13.92   Max: -0.38
Current: -1.13

During the past 12 years, the highest EV-to-FCF of Oxford BioDynamics was -0.38. The lowest was -114.45. And the median was -13.92.

STU:LMQ's EV-to-FCF is ranked worse than
100% of 433 companies
in the Biotechnology industry
Industry Median: 3.34 vs STU:LMQ: -1.13

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-01), Oxford BioDynamics's stock price is €0.0035. Oxford BioDynamics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.053. Therefore, Oxford BioDynamics's PE Ratio (TTM) for today is At Loss.


Oxford BioDynamics EV-to-FCF Historical Data

The historical data trend for Oxford BioDynamics's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics EV-to-FCF Chart

Oxford BioDynamics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.63 -4.80 -2.74 -8.44 -1.20

Oxford BioDynamics Semi-Annual Data
Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.74 - -8.44 - -1.20

Competitive Comparison of Oxford BioDynamics's EV-to-FCF

For the Biotechnology subindustry, Oxford BioDynamics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's EV-to-FCF falls into.


;
;

Oxford BioDynamics EV-to-FCF Calculation

Oxford BioDynamics's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=14.596/-12.745
=-1.15

Oxford BioDynamics's current Enterprise Value is €14.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford BioDynamics's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €-12.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics  (STU:LMQ) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Oxford BioDynamics's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0035/-0.053
=At Loss

Oxford BioDynamics's share price for today is €0.0035.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford BioDynamics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.053.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Oxford BioDynamics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines